HLA-B*3505 allele is a strong predictor for nevirapine-induced skin adverse drug reactions in HIV-infected Thai patients-Reference-Cited by-同舟云学术

HLA-B*3505 allele is a strong predictor for nevirapine-induced skin adverse drug reactions in HIV-infected Thai patients

Published:2009-02 Issue:2 Volume:19 Page:139-146
ISSN:1744-6872
Container-title:Pharmacogenetics and Genomics
language:en
Short-container-title:

Author:

Chantarangsu Soranun,Mushiroda Taisei,Mahasirimongkol Surakameth,Kiertiburanakul Sasisopin,Sungkanuparph Somnuek,Manosuthi Weerawat,Tantisiriwat Woraphot,Charoenyingwattana Angkana,Sura Thanyachai,Chantratita Wasun,Nakamura Yusuke

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Genetics(clinical),Genetics,Molecular Biology,Molecular Medicine,General Pharmacology, Toxicology and Pharmaceutics

Reference29 articles.

1. Thailand's do-it-yourself therapy;Cohen;Science,2003

2. Safety profile of nevirapine, a nonnucleoside reverse transcriptase inhibitor for the treatment of human immunodeficiency virus infection;Pollard;Clin Ther,1998

3. Adverse effects of antiretroviral therapy;Carr;Lancet,2000

4. Incidence and risk factors for nevirapine-associated rash;De Maat;Eur J Clin Pharmacol,2003

5. Incidence and risk factors for rash in Thai patients randomized to regimens with nevirapine, efavirenz or both drugs;Ananworanich;AIDS,2005

Cited by 164 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug hypersensitivity linked to genetic variations of human leukocyte antigen;Therapeutic Drug Monitoring;2024

2. Pembrolizumab-induced Stevens-Johnson syndrome/Toxic Epidermal Necrolysis in a Vietnamese patient with nonsmall-cell lung cancer;Asia Pacific Allergy;2023-12-18

3. Molecular insights into the HLA‐B35 molecules' classification associated with HIV control;Immunology & Cell Biology;2023-10-09

4. Advances in understanding of the pathogenesis and therapeutic implications of drug reaction with eosinophilia and systemic symptoms: an updated review;Frontiers in Medicine;2023-06-29

5. Updates on the immunopathology and genomics of severe cutaneous adverse drug reactions;Journal of Allergy and Clinical Immunology;2023-02